ENU200 has demonstrated specific antiviral activity against two SARS-CoV-2 proteins, S glycoprotein and Mpro ALPHARETTA, Ga., April 2, 2020 /PRNewswire/ -- Ennaid Therapeutics, LLC,...
International Society of Neglected Tropical Diseases: Discovery, Development, & Diagnostics Conference (ISNTD d3) May 25-26, 2016 Darnisha Harrison Interview: ...
Here is a copy of the Nature Medicine article in which Ennaid Therapeutics is mentioned. You can find us on...
This Week's Women in Technology Thought Leader: Darnisha Grant Harrison Despite the odds being stacked against them, women founders are currently excelling...
[vc_row row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css_animation=""][vc_column][vc_video link="https://youtu.be/bo6d6t1cr_o"][/vc_column][/vc_row]...
Researchers hope that understanding the ‘mechanism of action’ of a well-established HIV treatment could lead to the development of a...
Ennaid Therapeutics' CEO Darnish Harrison was featured on the Podcast, Taking Stock. Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE:...
Ennaid Therapeutics was mentioned in an article regarding Zika therapeutics that was just published in the August, 2016 issue of Nature Medicine. [pdf-embedder...
See us TODAY, 6/7/16, on CBS46 Atlanta at 12:00 pm, 4:00 pm, & 6:00pm!!! http://www.cbs46.com/story/32158848/cure-for-zika-could-be-made-available-soon...
ALPHARETTA, Ga., May 23, 2016 /PRNewswire/ -- The President and CEO of Ennaid Therapeutics, Darnisha Harrison, will be speaking at the 2016 ISNTD...
